Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
451
datasets available to search
ShareScore release 0.9.0
Dataset results
451 results for “AMD”
A Dose Ranging Study of OPT-302 With Ranibizumab in Neovascular (Wet) AMD
ClinicalTrials.gov study NCT03345082. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Evaluation of the Usefulness of a Treat and Extend Regimen Using Ranibizumab for Neovascular AMD.
ClinicalTrials.gov study NCT02321839. IPD Sharing: NO. Countries: 1. Publications: 1.
TAB014(Drug Code) in Wet( Neovascular)Age-related Macular Degeneration(AMD) Subjects
ClinicalTrials.gov study NCT03675880. IPD Sharing: NO. Countries: 1. Publications: 9.
Macular Pigment Density Evolution in Unilateral Wet AMD Versus Non AMD Patients With or Without Lutein and Zeaxanthine Supplementation
ClinicalTrials.gov study NCT01404845. IPD Sharing: Not stated. Countries: 1. Publications: 27.
Evaluation of Therapeutic Efficacy of Faricimab for Clinical AMD, DME, and RVO Patients
ClinicalTrials.gov study NCT06572553. IPD Sharing: NO. Countries: 1. Publications: 3.
Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular AMD
ClinicalTrials.gov study NCT01835067. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma
ClinicalTrials.gov study NCT06593405. IPD Sharing: YES. Countries: 1. Publications: 1.
The Ranibizumab Plus Transpupillary Thermotherapy for Neovascular Age-Related Macular Degeneration (AMD) Study
ClinicalTrials.gov study NCT00599222. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation on Optical Density of AMD Patients (LUTEGA)
ClinicalTrials.gov study NCT00763659. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Prospective OCT Study With Lucentis for Neovascular AMD (PrONTO Study)
ClinicalTrials.gov study NCT00344227. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Deciphering AMD by Deep Phenotyping and Machine Learning- Prospective Study - PINNACLE
ClinicalTrials.gov study NCT04269304. IPD Sharing: YES. Countries: 3. Publications: 1.
CNV in AMD Analyzed by OCT Angiography Under IntravitreaL Eylea (COCTAEyl)
ClinicalTrials.gov study NCT03803631. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Microperimetry and Eye Progressing From Stage 3 to Stage 4 Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT02395757. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Real Life of Aflibercept in France in Patients Refractory to Ranibizumab: Observational Study in Wet AMD
ClinicalTrials.gov study NCT02321241. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Omega 6:Omega 3 Ratio and Progression of Age-related Macular Degeneration (AMD).
ClinicalTrials.gov study NCT00987129. IPD Sharing: Not stated. Countries: 1. Publications: 7.
A Dose Escalation Trial of an Intravitreal Injection of Sirna-027 in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT00363714. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluation of Safety and Efficacy of Once Monthly Ranibizumab Injections in Chinese Patients With Wet Age Related Macular Degeneration (AMD) Patients
ClinicalTrials.gov study NCT00826371. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD
ClinicalTrials.gov study NCT02463344. IPD Sharing: NO. Countries: 1. Publications: 2.
Systemic Reactions to Allergen Immunotherapy Amd Skin Testing
ClinicalTrials.gov study NCT00594802. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of rhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT00090623. IPD Sharing: Not stated. Countries: 1. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.